Measurement of coronary calcium scores by electron beam computed tomography or exercise testing as initial diagnostic tool in low-risk patients with suspected coronary artery disease by Geluk, Christiane A. et al.
Eur Radiol (2008) 18: 244–252
DOI 10.1007/s00330-007-0755-2 CARDIAC
Christiane A. Geluk
Riksta Dikkers
Patrick J. Perik
René A. Tio
Marco J. W. Götte
Hans L. Hillege
Rozemarijn Vliegenthart
Janneke B. Houwers
Tineke P. Willems
Matthijs Oudkerk
Felix Zijlstra
Received: 13 November 2006
Revised: 26 July 2007
Accepted: 23 August 2007
Published online: 28 September 2007
# European Society of Radiology 2007
Measurement of coronary calcium scores
by electron beam computed tomography
or exercise testing as initial diagnostic tool
in low-risk patients with suspected coronary
artery disease
Abstract We determined the effi-
ciency of a screening protocol based
on coronary calcium scores (CCS)
compared with exercise testing in
patients with suspected coronary ar-
tery disease (CAD), a normal ECG
and troponin levels. Three-hundred-
and-four patients were enrolled in a
screening protocol including CCS by
electron beam computed tomography
(Agatston score), and exercise testing.
Decision-making was based on CCS.
When CCS≥400, coronary angio-
graphy (CAG) was recommended.
When CCS<10, patients were dis-
charged. Exercise tests were graded as
positive, negative or nondiagnostic.
The combined endpoint was defined
as coronary event or obstructive CAD
at CAG. During 12±4 months,
CCS≥400, 10–399 and <10 were
found in 42, 103 and 159 patients and
the combined endpoint occurred in 24
(57%), 14 (14%) and 0 patients (0%),
respectively. In 22 patients (7%),
myocardial perfusion scintigraphy
was performed instead of exercise
testing due to the inability to perform
an exercise test. A positive, non-
diagnostic and negative exercise test
result was found in 37, 76 and 191
patients, and the combined endpoint
occurred in 11 (30%), 15 (20%) and
12 patients (6%), respectively.
Receiver-operator characteristics
analysis showed that the area under
the curve of 0.89 (95% CI: 0.85–0.93)
for CCS was superior to 0.69 (95% CI:
0.61–0.78) for exercise testing
(P<0.0001). In conclusion, measure-
ment of CCS is an appropriate initial
screening test in a well-defined low-
risk population with suspected CAD.
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Introduction
The management of patients presenting with chest pain
remains a major challenge. Although the majority is at low
risk of acute coronary syndrome (ACS), obstructive
coronary artery disease (CAD) is present in 20% of
patients [1]. Furthermore, at least 2% of patients with ACS
are mistakenly discharged, resulting in increased mortality
[2].
Clinical assessment, an electrocardiogram (ECG), and
cardiac markers, such as troponin, allow initial discrimi-
nation between a high- and low-risk of ACS [3]. However,
risk stratification often requires additional diagnostic
testing. Exercise testing and measurement of CCS are fre-
quently used for coronary risk stratification [4–9]. How-
ever, exercise testing has a sensitivity and specificity for
obstructive CAD of 68% and 77%, respectively, while
sensitivity for left main/three-vessel CAD is 86% [10].
Therefore, exercise testing does not detect all patients with
(severe) obstructive CAD and the finding of a negative test
does not rule out the presence of CAD [1]. Measurement of
coronary calcium scores (CCS) may provide more effective
triage. The finding of any coronary calcium has a 93–99%
sensitivity and 23–75% specificity for obstructive CAD,
while the negative predictive value ranges from 95 to 100%
[7, 8, 11–16]. A few studies have studied the value of CCS
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results [6–8]. However, studies comparing CCS and
exercise tests have included only patients selected by
abnormal exercise tests [17] or the need of coronary
angiography [18, 19]. We therefore evaluated a screening
protocol based on CCS in low-risk patients suspected of
CAD and compared these findings with exercise test
results.
Materials and methods
Patients
Consecutive low-risk patients with chest pain or other
symptoms of CAD were included. Low-risk was defined as
a normal 12-lead ECG, normal troponin, no hemodynamic
instability and no abnormalities on physical examination or
chest roentgenogram. Coronary risk factors were assessed
by history and review of the medical record. Typical angina
was defined as the presence of retrosternal pain, increasing
with effort and responding to rest or nitroglycerin. If less
than three of these characteristics were fulfilled, or a patient
suffered from dyspnea, these patients were regarded as
having atypical complaints. Other symptoms suggestive of
CAD were arrhythmia, history of collaps or referral for
screening. Patients with previously documented CAD were
excluded. The pretest probability of significant CAD was
assessed according to the method by Pryor et al. [20]. A
high, and low test probability was defined as a probability
of equal to or higher than, and below 44%, respectively
[20].
Measurement of coronary calcium scores
Coronary calcium was measured using electron beam com-
puted tomography (EBCT) (e-Speed, GE Medical Systems,
South San Francisco, USA). According to patients’ weight
a n ds i z et h eb e a ms p e e dw a ss e tt o5 0m s( f o rs m a l lo rs l e n d e r
patients) or 100 ms (for larger patients). Prospective electro-
cardiographic triggering was used and set at 42% of the R-R
interval. Scans were made without the use of a contrast agent
with 130 kV and 895 mAs. A single collimation of 3.0 mm
and an increment of 3.0 mm was applied. Radiation
exposures were 0.3 mSv and 0.6 mSv for the 50 ms and
100 ms protocols, respectively. Individual exposures were not
measured. Assessment of all CCS was performed by one
reviewer blinded to the clinical data and the exercise test
results. The CCS was obtained by multiplying each area of
interest with a factor indicating peak density within the
individual area, as was proposed by Agatston et al. [21].
Exercise testing
Bicycle exercise tests were performed in accordance with
the guidelines [22, 23]. All tests were independently
reviewed by a cardiologist (R.T.) and a research physician
(C.G.), who reached a consensus in case of discriminative
results. Exercise test end points were defined as follows:
positive, in case of ECG evidence of myocardial ischemia
(0.1 mV horizontal shift of the ST segment at 80 ms after
the J point); intermediate, in case of 30 mmHg decrease in
systolic blood pressure and/or ventricular arrhythmia and/
or <0.1 mV ST depression and/or anginal complaints in the
absence of ECG evidence of ischemia; negative, in the
absence of any of the above mentioned criteria; and
noninterpretable, if <85% of the predicted heart rate or a
rate pressure product <18,000 was achieved. The predicted
heart rate was corrected for length, age and sex, making use
of a standardized table [24]. Intermediate and noninterpre-
table results are considered as “nondiagnostic results”.I n
case exercise testing was not possible, myocardial perfu-
sion imaging was performed.
Myocardial perfusion scintigraphy
Six-hundred MBq of
99 mTc-tetrofosmin was injected at
rest and the next day after adenosine or bicycle stress.
SPECTimages were acquired 1h after tracer administration
using a double-headed gamma-camera (Siemens E.Cam)
equipped with low-energy high-resolution collimators. The
camera heads were in perpendicular position. Other acqui-
sition parameters were: 32 steps rotation, 20 s per step,
128×128 matrix size, rotation from the 45° right anterior
oblique to the 135° left posterior oblique position with the
patient laying supine. The scans were reconstructed after
filtered-back-projection using a Butterworth 0.30/6 filter.
All data were reorientated in order to produce short-axis
(SA), horizontal long-axis (HLA) and vertical long-axis
(VLA) sections. The perfusion images were scored on
CAD by using a 17-segment polar map.
Screening protocol
The former screening protocol for low-risk patients with
chest pain included exercise testing. In the current study,
measurement of CCS was added. Exercise testing and
measurement of CCS were performed in random order.
Decision making was based on CCS (Fig. 1). In case of a
low CCS, defined as CCS<10, patients were discharged
and followed for the occurrence of cardiac events. In case
of a high CCS, defined as CCS≥400, coronary angiography
(CAG) was recommended to evaluate the presence of
obstructive CAD. In case of an intermediate CCS, defined
as CCS 10–399, primary prevention measures were recom-
mended, and the decision to perform additional testing was
245left to the judgment of the treating cardiologist. Both EBCT
and exercise testing were performed during office hours.
Therefore, in some patients the tests were performed
directly after presentation, while others were discharged
first and underwent the tests within 3 weeks at the
outpatient clinic. Follow-up was obtained in all patients
to determine the clinical status at least 4 months after the
measurement of CCS by review of the patient’s medical
record, telephone interviews of patients or general practi-
tioners. The project is part of a continuous quality-
improvement program of the Thoraxcenter, initiated by
the board of directors of the University Medical Center
Groningen. The protocol was approved by the Institutional
Review Board. Informed consent was given by all patients.
Angiographic analysis
All CAGs were analyzed by a senior cardiologist (F.Z.),
blinded to the clinical data. By qualitative analysis the
coronary arteries were graded as follows: normal coronary
arteries, defined as the absence of any coronary lesion;
non-obstructive CAD, if maximal luminal obstructions
were <50%; and obstructive CAD, if lesions obstructed the
lumen ≥50%.
Endpoints
The combined endpoint was defined as a combination of
the angiographic endpoint and a cardiac event. The
angiographic endpoint was defined as obstructive CAD at
CAG (≥50% luminal obstruction). Cardiac events were
defined as a revascularization procedure, myocardial
infarction or coronary death. Myocardial infarction was
defined as ST-elevation myocardial infarction (chest pain
and ST-elevation over 1 mm in at least two contiguous
leads) or non-ST-elevation acute coronary syndrome
[defined as chest pain with positive cardiac markers
(troponin or creatinin kinase) and/or dynamic ST-segment
changes] [25, 26]. Revascularization procedures included
percutaneous coronary intervention (PCI) and coronary
artery bypass graft surgery (CABG). Decisions to perform
a revascularization procedure were taken by the Thorax-
center multidisciplinary heart team, which has extensive
experience with the RAND-UCLA criteria and takes
decisions in accordance with the ESC and ACC/AHA
guidelines for PCI and CABG [27–31].
Statistical analysis
Continuous data are expressed as mean ± standard devia-
tion. Significance was reached when P<0.05. To compare
the diagnostic yield of CCS with exercise test results,
receiver operating characteristic (ROC) curve analysis was
performed, and positive and negative predictive values
were measured. We compared the area under the curves
(AUCs) of both tests for the combined endpoint in all
patients and after exclusion of subjects with typical angina.
Additional analysis on clinical outcome was performed in
those patients in whom exercise testing was not possible
and myocardial perfusion scintigraphy was performed, and
in those with CCS≥400 in whom the cardiologist decided
not to perform CAG. Calculations were performed using
the statistical package SPSS version 12.0 (SPSS, Chicago,
USA) and STATA 9.0 (College Station, Tex., USA).
Results
Baseline characteristics
From May 2004 till September 2005, 304 patients were
consecutively enrolled. Of all exercise tests performed
during this period in patients without previous CAD, 90%
were included in the study. Clinical characteristics are
shown in Table 1. Most patients (n=225) underwent diag-
nostic testing for atypical complaints. Typical anginal
complaints were present in 59 patients, while in 20 patients
diagnostic testing was performed for routine screening
(n=10), collapse (n=3) or arrhythmia (n=7). The large
majority (84%) had a low pretest probability of significant
CAD. In 22 patients (7%) myocardial perfusion scintigra-
phy was performed instead of exercise testing due to the
inability to perform an exercise test. The study population
represented 90% of the exercise tests performed in new
patients.
Follow-up
Follow-up was obtained in all 304 patients (100%). During
12±4 months, 83 CAGs were performed. In 38 patients
suspected coronary heart
disease?
delta ECG or ↑ Troponin?
yes
Exercise test and                              
EBCT (Agatston score)
< 10
10-399 at least primary prevention measures required
follow up visits discouraged
coronary angiography recommended
no
exclusion
previous documented CAD?
yes
exclusion
yes
no
≥ 400
Fig. 1 Flow chart
246obstructive CAD was found, followed by a revasculariza-
tion procedure in 28 patients (21 PCIs and 11 CABGs)
(Tables 2, 3). No myocardial infarctions or deaths occurred.
Coronary calcium scores by computed tomography
Low, intermediate and high CCS were detected by EBCT
in 159 (52%), 103 (34%) and 42 (14%) patients, re-
spectively. In one patient (0.3%) the CCS quantification
failed due to respiration artifacts. In this patient calcium
was visible in all coronary arteries and was graded to be of
intermediate amount.
Calcium score ≥400
In 42 patients with a high CCS, positive, negative and
nondiagnostic exercise test results were present in 13, 15
and 14 patients, respectively. These results are presented in
Table 2. In 37 patients a CAG was performed, showing
one- or two-vessel disease in 15 (40%) and three-vessel or
left main disease in nine (24%) patients (Table 3). In five
patients CAG was not performed because symptoms
disappeared with anti-ischemic medication. All patients
with CAD received pharmacologic therapy, a revascular-
ization procedure was performed in 17 patients. No
myocardial infarctions or deaths occurred. The combined
endpoint was observed in 24 of 42 (57%) patients.
Calcium score 10–399
In 103 patients with an intermediate CCS, most patients
had negative (n=63) or nondiagnostic (n=31) exercise test
results, while the remainder (n=9) had positive exercise test
results (Table 2). In 33 patients a CAG was performed,
Table 1 Baseline characteristics (LDL low-density lipoprotein,
HDL high-density lipoprotein)
Characteristics n=304
Age, mean (range), years 55 (26–85)
Male gender, n (%) 169 (56)
Current Smoking, n (%) 109 (38)
Diabetes, n (%) 37 (13)
Blood pressure, mean (SD), mm Hg
Systolic 141 (81)
Diastolic 81 (12)
Cholesterol, mean (SD), mg/dl
Total 208 (46)
LDL 124 (39)
HDL 54 (14)
Glucose, mean (SD), mmol/l 5.8 (1.9)
Hypertension, n (%) 113 (38)
Hypercholesterolemia, n (%) 128 (44)
Positive family history, n (%) 157 (54)
Medication, n (%)
ASA 59 (19)
Betablocker 75 (25)
Statin 75 (25)
Anginal complaints, n (%)
Typical angina 59 (19)
Atypical complaints 225 (74)
Other
a 20 (7)
Pretest probability of obstructive CAD
b (%) 15 (0–36)
Pretest probability of obstructive CAD, n (%)
High (≥44%) 49 (16)
Low (<44%) 255 (84)
aSee text for explanation
bMedian (p25-p75)
Table 2 Numbers of angiographic endpoints and cardiac events during follow-up (within 12±4 months)
Calcium score Result of exercise test n (%) No. of angiographic
endpoints
a
No. of cardiac events
a
≥400 (n=42) Positive 13/42 (31%) 7 7 (revascularization)
Negative 15/42 (36%) 8 5 (revascularization)
Nondiagnostic 14/42 (33%) 9 5 (revascularization)
10–399 (n=103) Positive 9/103 (9%) 4 4 (revascularization)
Negative 63/103 (61%) 4 3 (revascularization)
Nondiagnostic 31/103 (30%) 6 4 (revascularization)
<10 (n=159) Positive 15/159 (9%) 0 0
Negative 113/159 (71%) 0 0
Nondiagnostic 31/159 (20%) 0 0
aDefinitions of endpoints: angiographic endpoint ≥50% luminal obstruction at coronary angiography; cardiac event coronary death,
myocardial infarction or revascularization procedure
247showing obstructive CAD in 14 patients (Tables 2, 3). In
these 14 patients the CCS ranged from 23 to 379. All
patients with CAD received pharmacologic treatment, a
revascularization procedure was performed in nine pa-
tients. One patient presented with unstable angina 4 months
after PCI due to in-stent-restenosis and underwent repeat
PCI. One patient underwent re-PCI for stable angina. No
myocardial infarctions or deaths occurred. The combined
endpoint occurred in 14 of 103 (14%) patients.
Calcium score <10
In 159 patients with a low CCS, the majority had a negative
exercise test result (n=113), but positive and nondiagnostic
tests were present in, respectively, 15 and 31 patients. In 13
patients CAG was performed for the following reasons:
abnormal exercise test or myocardial perfusion scintigra-
phy (n=7); typical angina (n=2) and miscellaneous reasons
(n=4). In none of these patients obstructive CAD was
found (Tables 2, 3). The combined endpoint therefore
occurred in 0 (0%) patients.
Comparison with exercise testing
A positive, nondiagnostic and negative exercise test was
present in 37 (12%), 76 (25%) and 191 patients (73%),
respectively. The rates of high, intermediate and low CCS
in these groups were, respectively, 35%, 24% and 41%
(positive exercise test); 18%, 41% and 41% (nondiagnostic
exercise test); and 8%, 33% and 59% (negative exercise
test). The rates of the combined endpoint in the groups with
positive and negative exercise test results were, respec-
tively,30% (11/37) and 6% (12/191). A combined endpoint
occurred in 15 (20%) of the 76 subjects with an interme-
diate exercise test result, namely in nine of 39 subjects with
a nondiagnostic test results and in six of 37 subjects with an
noninterpretable exercise test result. The rates of the com-
bined endpoint according to CCS and exercise test results
are shown in Fig. 2. ROC statistics show an AUC of 0.89
(0.85–0.93) for CCS and 0.69 (0.61–0.78) for exercise
testing (P<0.0001; Fig. 3). A CCS>400 yielded a positive
predictive value of 57% (41–72%), while the negative
predictive value of a CCS<10 was 100% (98–100%). The
positive predictive vale of a positive exercise test was 30%
(16–47%; P>0.05 compared with CCS>400). The negative
predictive value of a negative exercise test result was 94%
(89–97%; P<0.05 compared with CCS<10). The AUC for
CCS and exercise testing were 0.90 (0.86–0.95) and 0.67
(0.57–0.77) for subjects with a low pretest probability of
C A D,a n d0 . 8 1( 0 . 6 8 –0.94) and 0.88 (0.76–0.99) for
subjects with a high pretest probability of CAD, respectively.
After exclusion of 59 patients with typical angina, ROC
analysis showed an AUC of 0.93 (0.88–0.97) for CCS and
0.64 (0.51–0.78) for exercise testing (P<0.001). Additional
analysis was performed in 277 patients, after exclusion of
five patients with CCS ≥400 without CAG and 22 patients
with myocardial perfusion imaging instead of exercise
testing. The combined endpoint occurred in 21 (64%) of 33
patients with CCS≥400; in 11 (12%) of 93 patients with
CCS 10–400, and in 0 (0%) of 151 patients with CCS<10.
The combined endpoint occurred in eight (32%) of 25
patients with positive exercise test results, in 15 (20%) of
74 patients with nondiagnostic exercise test results, and in
nine (5%) of 178 patients with negative exercise test
results. ROC statistics show an AUC of 0.91 (0.86–0.95)
for CCS and 0.72 (0.62–0.82) for exercise testing (P<0.001).
Table 3 Coronary angiographic findings
Calcium
score
CAG,
n
Normal coronary
arteries, n (%)
Nonobstructive
CAD, n (%)
One-vessel disease,
n (%)
Two-vessel
disease, n (%)
Three-vessel or left main
disease, n (%)
≥400
(n=42)
37 1 (3) 12 (33) 9 (24) 6 (16) 9 (24)
10–399
(n=103)
33 5 (15) 14 (43) 10 (30) 2 (6) 2 (6)
<10
(n=159)
13 11 (85) 2 (15) 0 0 0
0%
10%
20%
30%
40%
50%
60%
CCS <10; 11-399; >=400 negative; nondiagnostic; positive
exercise test
0% 
14% 
57% 
6% 
20% 
30% 
Fig. 2 Outcome according to CCS and exercise testing. The
percentage of patients with the combined endpoint are shown per
group
248Discussion
The results of this study confirm that measurement of CCS
provides effective triage in a well-defined patient group
with suspected but low risk of coronary artery disease. In
addition, our results indicate that the diagnostic yield of
CCS is superior to exercise testing. We included only low-
risk patients, which was defined as the absence of prior
evidence of CAD, an abnormal 12-lead ECG or elevated
serum cardiac markers. The major clinical advantage of our
strategy has been facilitation of safe discharge from the
hospital in a majority (52%) of these patients, as defined by
a low CCS derived from CT. The diagnostic efficacy of our
strategy is further demonstrated by high rates of obstructive
CAD (especially three-vessel and left main disease) and
revascularization procedures in patients with a high CCS.
Measurement of CCS and exercise testing provide
fundamentally different diagnostic information. The first
test provides information on the amount of calcium in the
coronary arteries, while the second test’s purpose is to
detect myocardial ischemia. Both an “anatomical” and
“functional” approach as initial diagnostic tests in patients
with suspected CAD may lead to effective risk stratifica-
tion [1, 4]. The few studies on risk stratification based on
CCS in low-risk patients with chest pain have shown
promising results [6–8]. However, studies comparing CCS
with exercise testing have not yet been performed in low-
risk populations [18, 19]. The former approach at our
institution was exercise testing. This was replaced by a
protocol in which all patients underwent both exercise
testing and CT, and decision making was based on CCS.
The efficiency of the current protocol was confirmed by the
following observations. First, during a mean follow-up of
12±4 months, no single hard event (myocardial infarction
or death) occurred. Second, a large majority (57%) of
patients with CCS≥400 had obstructive CAD, and 21% had
three-vessel or left main disease. In a majority of these
patients a revascularization procedure was necessary
according to the ESC and ACC/AHA guidelines for PCI
and CABG [27–31]. In subjects with a CCS<10, no
coronary events occurred during follow-up. This contrasts
with the exercise test results, with 6% of patients with
negative exercise test results having obstructive CAD. The
high negative predictive value of a low CCS is in concert
with many earlier studies [8, 11, 14].
Another major advantage of measurement of CCS may
become the detection of minor degrees of CAD. In 34%
and 25%, respectively, of our study population, an inter-
mediate amount of coronary calcium and a nondiagnostic
exercise test result was present. In patients with CCS
10–399, the presence of CAD has been confirmed and
therefore the initiation of primary prevention measures
such as life style modification, aspirin and/or statin
treatment can be initiated. In contrast to intermediate
CCS findings, when exercise testing provides nondiagnos-
tic results, uncertainty with regard to the presence of CAD
remains.
Some issues remain to be answered. Due to recent
technical improvements CCS can now also be measured by
multidetector computed tomography (MDCT) [32–40].
Differences between CCS measurements on EBCT and
MDCT have been shown to be similar to the reported
individual EBCT and MDCT interscan variabilities of
around 20% [32, 35]. Exclusion of coronary calcium by
MDCT is as feasible as by EBCT [41, 42]. Comparative
studies in low-risk patients with suspected CAD at our
department, and in large populations of asymptomatic
subjects [32], are currently underway.
We propose to use measurement of CCS as gatekeeper
for additional invasive and noninvasive testing [43]. Our
protocol enabled us to differentiate between high (CCS>400)
and low risk (<100) subjects. However, one-third of our
study population had an intermediate CCS (10–399) and
obstructive CAD was found in14% of these subjects. Ideally,
in this patient category, a test with high sensitivity for
myocardial ischemia should guide the decision to perform
CAG, in addition to pharmacologic treatment, as stated
above. However, so far, the evidence for use of a clinical
protocol in such patients is lacking. Exercise testing can not
fulfill this task. Stress echocardiography, myocardial perfu-
sion scintigraphy or stress cardiac magnetic resonance
imaging may be better options [44]. Another option is
MDCT coronary angiography, which may be clinically
useful an may may obviate the need of CAG when luminal
stenoses are ruled out [45]. The need for optimization of the
current protocol was highlighted by the observation that of
the 83 CAGs performed obstructive CAD was found in 38
(46%).
Finally, is CCS more accurate than MDCT coronary
angiography? So far, the role of MDCT coronary angiog-
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Fig. 3 ROC curves of CCS (<10, 10–399 and ≥400) and exercise
testing (negative, nondiagnostic, positive) for the combined end-
point. The difference in AUCs of both tests show the incremental
diagnostic yield of measurement of CCS when compared with
exercise testing (P<0.0001)
249raphy in the evaluation of patients with suspected CAD has
not become established. Compared with measurement of
CCS, the advantage of MDCTcoronary angiography lies in
its information on luminal stenosis [45, 46]. This probably
led to a higher number of patients that could be discharged
in the evaluation of chest pain in case of negative results
(68% with minimal or no stenoses [47] versus 52% with
CCS<10 in the current study).
However, since very low CCS are associated with a high
negative predictive value, performance of MDCTcoronary
angiography in such patients cannot be justified. We
believe that CT coronary angiography may play a role in
subjects with CCS>10. A recent study showed that, in a
population scheduled for CAG, the diagnostic yield of
MDCT coronary angiography was superior to exercise
testing [48]. Further studies are needed to establish the role
of MDCT coronary angiography in low risk subjects. In
addition, cost-effectiveness should be taken in mind, since
in patients with a high probability of CAD, direct CAG
may be more cost-effective than a strategy with MDCT
coronary angiography [49].
Remarks and limitations
We have chosen a follow-up study design. Our design was
limited by the absence of a “gold standard” in every
patient, since the procedure to determine the endpoints
was influenced by the test results. The absolute numbers
of obstructive CAD or clinical events according to
exercise test results may therefore have been somewhat
biased, since the screening protocol was based on CCS.
Furthermore, in patients with low CCS CAG was not
performed, thereby decreasing the likelihood of detecting
CAD. Our follow-up design restricted the evaluation of
cost-effectiveness, which is a limitation, since it was
shown that CCS measurement may not be cost-effective
[49]. Further studies should be performed to evaluate this
issue. Obstructive CAD was measured by qualitative
coronary analysis, which is less accurate when compared
to quantitative coronary analysis. For this low risk
population without previous CAD, symptoms by itself
during exercise testing cannot be classified as a positive
exercise test. Therefore, symptoms without ECG changes
were classified as an intermediate test result. We did not
report the intermediate and noninterpretable exercise test
results separately, but presented these as one (“nondiag-
nostic”) group, since both test outcomes do not provide
diagnostic certainty and clinical outcome was similar.
Conclusion
In patients with suspected CAD, with a normal ECG and
normal cardiac markers, a screening protocol based on
coronary calcium scores provides effective triage.
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